It is amazing that the left will put politics above people's life's, but I am not surprised. The left is the enemy of liberals and conservatives.
So he's giving then an anti-malarial/arthritis drug (effect on virus dubious at best)... An antibiotic...(Effect on virus non-existent) And a zinc supplement (Effect on virus non-existent) So the people got better on their own. Remember, these are out-patients. They went in with the sniffles, and came out with a bill for the visit and unneeded drugs, which will have the net effect of making any bacteria in their body more resistant to antibiotics in the future. Smooth move Dr. Ex-Lax. Oh, just noticed in the tweet name. Doctor Doug is a DENTIST! Rofflecopter
a British study on Hydro... is underway. Funded by Gates. Hydro... enhances absorbtion of zinc into the cytosol inside the cells, that's all. That's the mechanism of action. No mystery, not rocket science, not costly at all. The British study does not supply short term additional Zinc. The study will fail. The study is designed to fail. The study will be under the headline "We Told You So" Discerning folks have free access to these compounds. It is a free country afterall. word. could you pass the grey poupon please?
hydro... treatment $20.00 or gilead product $5700.00 such a deal. Foucher's pockets gonna overflow, lol.
Study finds hydroxychloroquine helped coronavirus patients survive better By Maggie Fox, Andrea Kane, and Elizabeth Cohen, CNN Updated 11:24 PM EDT, Thu July 02, 2020 https://www.cnn.com/2020/07/02/health/hydroxychloroquine-coronavirus-detroit-study/index.html
@gwb-trading What do you think about this new study? Also, @Here4money what do you think? If this study is accurate, liberals and libtard MSM have blood on their hands. Also, if I remember correctly, according to the below results, hydroxychloroquine is by far the best treatment. Just look at that p value. Neither drug 26.4% mortality Hydroxychloroquine alone 13.5% mortality Hydroxychloroquine + azithromycin 20.1% mortality Hydroxychloroquine provided a 66% hazard ratio reduction Hydroxychloroquine + azithromycin 71% hazard ratio reduction p < 0.001 https://www.ijidonline.com/article/S1201-9712(20)30534-8/fulltext Results Of 2,541 patients, with a median total hospitalization time of 6 days (IQR: 4-10 days), median age was 64 years (IQR:53-76 years), 51% male, 56% African American, with median time to follow-up of 28.5 days (IQR:3-53). Overall in-hospital mortality was 18.1% (95% CI:16.6%-19.7%); by treatment: hydroxychloroquine + azithromycin, 157/783 (20.1% [95% CI: 17.3%-23.0%]), hydroxychloroquine alone, 162/1202 (13.5% [95% CI: 11.6%-15.5%]), azithromycin alone, 33/147 (22.4% [95% CI: 16.0%-30.1%]), and neither drug, 108/409 (26.4% [95% CI: 22.2%-31.0%]). Primary cause of mortality was respiratory failure (88%); no patient had documented torsades de pointes. From Cox regression modeling, predictors of mortality were age>65 years (HR:2.6 [95% CI:1.9-3.3]), white race (HR:1.7 [95% CI:1.4-2.1]), CKD (HR:1.7 [95%CI:1.4-2.1]), reduced O2 saturation level on admission (HR:1.5 [95%CI:1.1-2.1]), and ventilator use during admission (HR: 2.2 [95%CI:1.4-3.3]). Hydroxychloroquine provided a 66% hazard ratio reduction, and hydroxychloroquine + azithromycin 71% compared to neither treatment (p < 0.001). Conclusions and Relevance In this multi-hospital assessment, when controlling for COVID-19 risk factors, treatment with hydroxychloroquine alone and in combination with azithromycin was associated with reduction in COVID-19 associated mortality. Prospective trials are needed to examine this impact.
It looks as though one of the major medical issues with Covid-19 is blood clotting. Perhaps the best treatment is a blood thinner, anti-inflammatory steroid, and hydroxycloroquine. It will be interesting if there are any medical studies that administer that combination. https://www.sciencedaily.com/releases/2020/06/200630125129.htm Changes in blood platelets triggered by COVID-19 could contribute to the onset of heart attacks, strokes, and other serious complications in some patients who have the disease, according to scientists. The researchers found that inflammatory proteins produced during infection significantly alter the function of platelets, making them 'hyperactive' and more prone to form dangerous and potentially deadly blood clots.